Benjamin Daniel Odell I, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 |
Sheila Anne Lewicki, Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 37782 Hatteras Way, Avon, OH 44011 Phone: 440-567-8113 |
Mary C Winship, CNP Registered Nurse - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 33355 Health Campus Blvd, Avon, OH 44011 Phone: 440-937-9099 Fax: 440-937-9755 |
Ms. Carmen M. Ruffin, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 36550 Chester Rd, #2203, Avon, OH 44011 Phone: 216-255-8508 |
Lore Michele Mcsweeney, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 38627 Camelot Way, Avon, OH 44011 Phone: 440-610-1825 |
Janel D Vansickle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2582 Shakespeare Ln, Avon, OH 44011 Phone: 216-544-8113 Fax: 216-445-3692 |
Ms. Diane J Weisenberger, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 33100 Cleveland Clinic Blvd, Avon, OH 44011 Phone: 440-695-4000 |
Heather Quinn Cassidy-drain, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2455 Stonefield Dr, Avon, OH 44011 Phone: 440-934-0509 |
News Archive
A new model of pneumatic muscle and an active type of assistive equipment incorporating this pneumatic muscle has been developed at Hiroshima University and Daiya Industry Co. Ltd., Japan.
ReCor Medical, an emerging medical device company, announced today that it has completed enrollment in the REDUCE 15-patient pilot clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).
The global economic downturn caused the growth in wages worldwide to be halved in 2008 and 2009, according to the International Labour Organisation's (ILO) recent Global Wage Report, Agence France-Presse reports (12/16).
With fewer than 4,000 residents, the genetically isolated Micronesian island of Kosrae, in the West Pacific, provides an ideal population in which to research heritability of disease.
› Verified 2 days ago